Grant: Doctoral Research Award - PA - Bioinformatics and Computational Biology
University of Toronto
$120,000.00
Reaping Returns on Repair: Leveraging phased copy number and single nucleotide variants to improve DNA repair efficacy scoring for assessing genomic instability in tumours.
EF 2024-25
Résumé
Issues with DNA repair is a classic hallmark of cancer, via variants that are inherited or acquired in genes involved in repair. Clinicians use descriptors of repair, such as the number of acquired variants when making decisions, for example for therapeutics. Accordingly, clinicians use tools that class tumours into two bins, deficient or proficient for a given repair pathway. It is clear these methods can be improved upon by including a diversity of mutations, considering multiple repair pathways, and accounting for tissue-specific effects relevant to the cancer type. These issues establish a need for a new tool, which addresses these shortcomings. I hypothesize repair scores I calculate will be correlated with the number of acquired variants, help predict drug response and help describe patterns of tumour evolution.
I will develop an improved method for scoring repair. I will use different types of mutations identified through tumour and normal samples from the 100,000 Genomes Project. I will use information about which allele has been impacted by variants to assess the overall function of the gene. I will use variants from across a pathogenicity spectrum. The function I will create will describe both universal and pathway-level repair using a gene-level analysis. The impact of variants in a particular gene will be scaled by features such as how important the region is for selection or the pathway, how tolerant it is to duplications or deletions, and how essential it is to the cancerous tissue. I will ensure my tool produces logical results by benchmarking with established methods. Next, I will deploy my method to samples from the Hartwig Medical Foundation. I will use my model to help describe how each pathway contributes to predicting the rate of acquired variants and treatment response, as well as patterns in tumour evolution.
My goal is to improve upon methods by integrating a comprehensive view of mutations, their impact, and their relationship to cancer.
Programme
Doctoral Research Award - PA - Bioinformatics and Computational Biology
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
519310
Name
Boev Nadejda B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Reaping Returns on Repair: Leveraging phased copy number and single nucleotide variants to improve DNA repair efficacy scoring for assessing genomic instability in tumours.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA - Bioinformatics and Computational Biology
Keyworddelim
Clonal Evolution; Dna Repair; Drug Response; Tumour Mutational Burden; Whole Genome Sequencing
Abstract
Issues with DNA repair is a classic hallmark of cancer, via variants that are inherited or acquired in genes involved in repair. Clinicians use descriptors of repair, such as the number of acquired variants when making decisions, for example for therapeutics. Accordingly, clinicians use tools that class tumours into two bins, deficient or proficient for a given repair pathway. It is clear these methods can be improved upon by including a diversity of mutations, considering multiple repair pathways, and accounting for tissue-specific effects relevant to the cancer type. These issues establish a need for a new tool, which addresses these shortcomings. I hypothesize repair scores I calculate will be correlated with the number of acquired variants, help predict drug response and help describe patterns of tumour evolution.
I will develop an improved method for scoring repair. I will use different types of mutations identified through tumour and normal samples from the 100,000 Genomes Project. I will use information about which allele has been impacted by variants to assess the overall function of the gene. I will use variants from across a pathogenicity spectrum. The function I will create will describe both universal and pathway-level repair using a gene-level analysis. The impact of variants in a particular gene will be scaled by features such as how important the region is for selection or the pathway, how tolerant it is to duplications or deletions, and how essential it is to the cancerous tissue. I will ensure my tool produces logical results by benchmarking with established methods. Next, I will deploy my method to samples from the Hartwig Medical Foundation. I will use my model to help describe how each pathway contributes to predicting the rate of acquired variants and treatment response, as well as patterns in tumour evolution.
My goal is to improve upon methods by integrating a comprehensive view of mutations, their impact, and their relationship to cancer.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Boev, Nadejda B
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~